Success Stories: EB-1A Petition Approved in 12 days for Jr. Specialist/PhD Researcher in California in the Field of Biochemistry (With PP, No RFE)

Client’s Testimonial:

“Thanks for all your help to finish my case. I appreciate your detail and professional services. I will recommend your firm to all my friend who need the service.”

On January 9^th, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Jr. Specialist/PhD Researcher in the Field of Biochemistry (Approval Notice).

General Field: Biochemistry

Position at the Time of Case Filing: Jr. Specialist/PhD Researcher

Country of Origin: China

Service Center: Nebraska Service Center (NSC)

State of Residence at the Time of Filing: California

Approval Notice Date: January 9^th, 2017

Processing Time: 12 days (Premium Processing Requested)

Case Summary:

A Chinese Jr. Specialist/PhD researcher specializing in biochemistry sought assistance from our firm — North America Immigration Law Group (NAILG) — to help him with the first step of the green card process: filing an I-140 petition. With extensive research experience and significant contributions made to the field of biochemistry, our client was a suitable candidate for EB-1A (Alien of Extraordinary Ability), one of the most stringent visa categories. After assessing his credentials, we were convinced that we could successfully obtain EB1A approval and we worked diligently to prove the value of his work to the United States.

Our client’s strong background in biochemistry, micro- and nanotechnology, and electronic materials has allowed his research to be particularly original, with applications such as the development of biosensors and bio-computing devices for the detection of DNA, proteins, small molecules, and ions. A landmark achievement in his research career has been the development of a method for colorimetric detection using gold nanoparticles and conjugated polyelectrolytes. It was our goal to present these splendid accomplishments to the adjudicating authorities.

In order to assemble a comprehensive EB1A petition encompassing every milestone in our client’s research career, we gathered information about his citation count, publication record, and peer review experience. At the time of filing, our client’s work had garnered a massive 792 citations and he had an impressive publication record of 10 peer-reviewed scientific articles. Moreover, he had served as a peer reviewer for 25 papers slated for publication in high impact journals. These achievements reflected our client’s exceptional caliber in the field of biochemistry.

Our client had also collected 4 recommendation letters from other renowned experts. These letters were incorporated into his petition packet to further strengthen it. The words contributed by a professor of biomedical engineering read:

“[Client] is a truly noteworthy individual who has gone above and beyond what is usually expected of and seen from other professionals in similar positions. With his research and discoveries bolstering the future of biosensor technology, he is clearly at the forefront of the field.”

These letters proved beyond doubt that our client is an expert in his chosen field and that his substantial contributions make him an asset to the American scientific community.

Our client’s EB1A petition was filed with Premium Processing (PP), a paid option which slices down the adjudication timeline from 4-9 months to 15 days or less (our client only waited 12 days for his petition to be approved). We congratulate him on this win and wish him the best as he gets closer to turning his green card dream into reality.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 47,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 47,000 in 2023.